Literature DB >> 34215466

An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.

Cintia R Prokopez1, Miguel Vallejos2, Lorena S Lopredo3, Luciano E Sfriso3, Luciana C Chiapella4, Claudio Arce3, Ricardo M Corral2, Manuel J Cuesta5, Romina Farinola2, Martín Alomo6.   

Abstract

Entities:  

Year:  2021        PMID： 34215466     DOI： 10.1016/j.schres.2021.06.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review.

Authors:  Marc De Hert; Victor Mazereel; Marc Stroobants; Livia De Picker; Kristof Van Assche; Johan Detraux
Journal:  Front Psychiatry       Date:  2022-01-13       Impact factor: 4.157

2.  Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?

Authors:  Cintia R Prokopez; Romina Farinola; Miguel Vallejos; Lorena S Lopredo; Luciano E Sfriso; Luciana C Chiapella; Claudio Arce; Ricardo M Corral; Manuel J Cuesta; Martín Alomo
Journal:  Schizophr Res       Date:  2022-01-24       Impact factor: 4.939

3.  Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.

Authors:  Katlyn Nemani; Sharifa Z Williams; Mark Olfson; Emily Leckman-Westin; Molly Finnerty; Jammie Kammer; Thomas E Smith; Daniel J Silverman; Jean-Pierre Lindenmayer; Gillian Capichioni; James Clelland; Donald C Goff
Journal:  JAMA Netw Open       Date:  2022-05-02

4.  Clozapine and COVID-19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study.

Authors:  Selene R T Veerman; Timo Moscou; Jan P A M Bogers; Dan Cohen; Peter F J Schulte
Journal:  Acta Psychiatr Scand       Date:  2022-04-01       Impact factor: 7.734
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.